Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Susan M Neeson"'
Autor:
Kim Linton, Timothy M Illidge, John Radford, Andrew R. Pettitt, E. Smith, Caroline Dive, Alastair Greystoke, Malcolm R Ranson, Grace Hampson, Andrew Lister, Adam Gibb, Peter Johnson, Susan M Neeson
Publikováno v:
British Journal of Cancer
Gibb, A, Greystoke, A, Ranson, M, Linton, K, Neeson, S, Hampson, G, Illidge, T, Smith, E, Dive, C, Pettitt, A, Lister, A, Johnson, P & Radford, J 2013, ' A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity ', BJC, vol. 109, no. 10, pp. 2560-2565 . https://doi.org/10.1038/bjc.2013.605
Gibb, A, Greystoke, A, Ranson, M, Linton, K, Neeson, S, Hampson, G, Illidge, T, Smith, E, Dive, C, Pettitt, A, Lister, A, Johnson, P & Radford, J 2013, ' A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity ', BJC, vol. 109, no. 10, pp. 2560-2565 . https://doi.org/10.1038/bjc.2013.605
Background:Myelotoxicity during initial cycles of chemotherapy for Hodgkin lymphoma is associated with better outcome, supporting the concept of individualised dosing based on pharmacodynamic end points to optimise results. This study was performed t
Autor:
Elaine Blowers, Fiona C Thistlethwaite, Michelle Davies, Susan M Neeson, Kim Linton, Evelyn Dolan
Publikováno v:
Annals of Oncology. 29:viii695-viii696
Autor:
Andrew Lister, Silvia Montoto, Peter Johnson, John Radford, Jonathan P. Kerr, Hannah Hunter, Susan M Neeson, Sandra J. Strauss, Ama Z. S. Rohatiner, Simon Rule, Agathoclis Agathocleous, Janet Matthews
Publikováno v:
British Journal of Haematology. 151:346-353
The combination of bortezomib and rituximab was evaluated in patients with mantle cell lymphoma (MCL), follicular lymphoma (FL) and Waldenstrom macroglobulinaemia (WM), in a Phase I and later, a randomized Phase II study. In the randomized study, 42
Autor:
Agathoclis, Agathocleous, Ama, Rohatiner, Simon, Rule, Hannah, Hunter, Jonathan Paul, Kerr, Susan M, Neeson, Janet, Matthews, Sandra, Strauss, Silvia, Montoto, Peter, Johnson, John, Radford, Andrew, Lister
Publikováno v:
British journal of haematology. 151(4)
The combination of bortezomib and rituximab was evaluated in patients with mantle cell lymphoma (MCL), follicular lymphoma (FL) and Waldenström macroglobulinaemia (WM), in a Phase I and later, a randomized Phase II study. In the randomized study, 42
Autor:
A. Z. S. Rohatiner, A. Agathocleous, N. Lafon, T. A. Lister, John Radford, Peter Johnson, Silvia Montoto, Jonathan P. Kerr, Hannah Hunter, Janet Matthews, Sandra J. Strauss, Susan M Neeson, Simon Rule
Publikováno v:
ResearcherID
Introduction: Rituximab (R) is an integral component of therapy for B-cell lymphoid malignancies; bortezomib (Btz) has shown provocative single agent activity in Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL) and Waldenström’s Macroglobulin